Fmoc-Ala-(Dmb)Gly-OH |
| カタログ番号GA21499 |
Dmb基は、偽プロリン残基と同様にFmoc-SPPS中の集合した配列を効率的に崩壊させます。Hmbジペプチドとは異なり、Dmbジペプチドはオキサゼピノンを形成することができないため、スムーズにカップリングされます。TFAクレイベージの最終段階でスカベンジャーが存在する場合、Dmbは除去されます。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1188402-17-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Introduction of the Dmb-moiety disrupts aggregated sequences during Fmoc-SPPS as efficiently as a pseudoproline residue. Dmb dipeptides couple smoothly, as, contrary to Hmb dipeptides, they cannot form oxazepinones. Dmb is removed during the final TFA
Average Rating: 5 (Based on Reviews and 28 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *